About Us

"Our 

mission 

at 

CAPNOS 

is 

to 

prevent 

lung 

disease 

and 

save 

lives."

OUR 

VALUES

People

We aim to help one million people quit vaping or smoking by 2026. We focus on the unique need for oral fixation cravings and stress relief alternatives to deliver an experience for anyone, anytime, anywhere..

Product

We bring affordable, accessible quit products that can be used by youth and adults. Our products are not vapes, nor tobacco products, as only air is inhaled, yet can be used for quitting, stimming, or relief.

Planet

Our products are made to last, with a base unit being reusable forever. By Zeroing instead of vaping disposable devices or cigarettes, there is a direct effect on offsetting waste. We're in this together!

OUR 

STORY

Brendan Wang was a high school freshman when he started vaping, and was then addicted for the next five years. In 2019, as a college sophomore, vaping deaths began occuring and his friends struggled to quit, despite apps, therapies, NRTs, and other solutions being available. 

However, there were virtually no solutions that could stimulate the enjoyable parts of vaping (tangible throat hit, auditory sound, and aroma) as a clean alternative, especially when a significant population has a behavioral craving. Brendan became obsessed with finding a solution, surveying thousands of vapers and smokers to become an expert on helping people quit successfully. 

During COVID-19, the CAPNOS team spent two years researching and developing the patent-pending Zero with multiple pilots yielding successful results, including Brendan being re-addicted to help himself quit vaping, yet again. In 2022, the Zero made its debut.

By early 2023, over 20,000 customers globally have purchased CAPNOS products to quit vaping or smoking. Physicians, pulmonologists, school administrators, parents, government officials, and especially our own customers have positively endorsed CAPNOS as an effective alternative for quitting vapes or cigarettes.

The team spans four continents and continues to grow in order to reach a portion of the one billion smokers globally, with 80% living in low-income regions, to prevent lung disease and save lives.

THE 

PSYCHOLOGY

Vaping has become such a routine part of our lives. Why do we vape so often and why is it so hard to quit? 

We often start due to social inclinations. Our friends are engaging in smoking or vaping, so why feel left out? Other times, it's just curiosity. Perhaps, it's for stress relief. As many products contain high levels of nicotine, an addiction rapidly forms and we are often left relying on our vapes or cigarettes as crutches, needing to be readily available. 

Over time, the continued use of nicotine builds a tolerance. That means, more hits / pulls have to occur to achieve anywhere near the satisfying buzz that happens at the start of the day. Eventually, the habit forms for an oral fixation, as the dependence shifts to the routine hand-to-mouth ritual as a coping mechanism for stress, anxiety, or as a pacifying act that can be done passively during other tasks. 

The addiction is now behavioral with a sensory dependence. If we can replicate the ritual, but breathe only natural air around us, then we can build mindful breathing habits that can ultimately lead to cessation success.  


*CAPNOS has surveyed thousands of potential and current customers to reach this understanding. Coupled with a pilot study that achieved 100% cessation success for nine tobacco quit clients, the team continues to advance scientific research on cessation applications from a behavioral lens. 

MEET 

OUR 

TEAM

MEET 

OUR 

TEAM

Bendan Wang

Founder and CEO

Alec Cherrin

VP of Operations and Growth Lead

Lorreta Imonikhe

Human Resources and Administrative Associate

Edin Mucic

Brand Development Specialist

Pierre Aguilar

Customer Success Specialist

Board of Advisors

Kavita Gunda Bouknight

MatchHealth CEO

Eric Achtyes, MD, MS

Chair of Psychiatry, WMU School of Medicine; Behavioral Health Director 

Mike Miller, PhD.

General Partner at Liquid 2 Ventures

Omari Bouknight

Abbott DVP Structural Heart